CovARC: a streamlined, scalable and accurate COVID-19 risk calculation system

In a recent paper published in the Nature Journal, researchers discussed the development of the coronavirus disease 2019 (COVID-19) Activity Risk Calculator (CovARC), a gamified tool to estimate infection risks associated with day-to-day activities during the COVID-19 pandemic.

This simple tool aims to help the public make informed decisions regarding engaging in various activities and reducing COVID-19 transmission.

Study: COVID-19 activity risk calculator as a gamified public health intervention tool. Image Credit: Drazen Zigic/Shutterstock.comStudy: COVID-19 activity risk calculator as a gamified public health intervention tool. Image Credit: Drazen Zigic/Shutterstock.com

Background

Varying risk levels have been identified for different activities and gatherings during the COVID-19 pandemic owing to factors such as precautions to prevent viral spread, vaccine efficacy, and COVID transmission rates.

This complexity in risk levels has resulted in confusion among the public regarding personal risk, which has led to the development of various tools to assess the risks.

However, currently available tools are inaccurate and overlook individual characteristics, leading to confusion around infection prevention strategies such as masking and vaccination. Since the determination of infection risk is crucial in the fight against the pandemic, there is an urgent need for accurate risk assessment tools.

Study

The present study describes the methods used in the development of CovARC. The tool uses various datasets from online sources, including variants and confirmed case datasets, COVID-19 Trends and Impact Survey on Facebook, the Johns Hopkins dataset, and the Centers for Disease Control and Prevention (CDC) variants dataset, to determine the number of active COVID-19 cases.

While the confirmed case dataset is updated daily, the variants dataset uses data from 31 days ago, as every variant is prevalent in the population for one month. The number of active cases is calculated by subtracting the confirmed cases on a given day from that of the previous day and calculating the 14-day aggregate.

CovARC also uses custom datasets such as the mask's fitted filtration efficacy (FFE) dataset and the vaccine efficacy against different viral variants dataset to estimate COVID-19 risk.

Additionally, the tool takes into account factors such as age, sex, indoor and outdoor environment, past illness, and viral variants on infection risk, hospital admission, and death in order to accurately assess the risks associated with various activities during the pandemic.

Results

The study results show the impact of vaccination and mask usage on infection risk during high case count periods. The researchers presented the range of risks of hospitalization and death in different scenarios, considering the impact of viral variants and the user’s health and demographic data.

The results show that CovARC uses various data sources and algorithms to assess the risk of infection, hospitalization, and death based on the data input by the user.

The risk assessment process involved extracting confirmed cases data from the Johns Hopkins dataset and cross-validating it with Facebook survey data, and then calculating the COVID-19 case density and adjusting it for the impact of variants, mask usage, and vaccination status.

The effectiveness of CovARC is shown through scenarios involving various age groups, mask types, vaccination statuses, and contact levels. The tool's user-friendly streamlined interface gives a range of risks rather than specific values.

Even as uncertainties persist in current methods used for COVID-19 risk estimation, this study shows CovARC as an accessible tool with the potential for COVID-19 risk reduction and public health education.

In the future, the researchers plan to add more parameters such as immunity, vaccination or infection-related health risks, and waning immunity to fine-tune the tool.

The study findings show the potential of the CovARC tool to empower the public to make informed decisions about safely engaging in various activities and reducing COVID-19 transmission.

Conclusions

To summarize, CovARC is a vital resource that can help the general public and policymakers determine COVID-19-related risks of infection, hospitalization, and mortality.

According to the authors, CovARC is simpler, more comprehensive, and more accurate than current alternatives, thanks to its streamlined interface that allows quick COVID-19 risk estimation.

The tool also takes into account factors such as gender, age, comorbidities, vaccination status, masks use, mask types, and the number of close contacts. Future directions include determining the impact of the CovARC tool on the level of COVID-19 community transmission.

This study contributes to public health by presenting a simple, scalable, yet accurate tool that estimates the COVID-19 transmission risk associated with various day-to-day activities during the pandemic.

Moreover, since CovARC considers factors such as variants of the virus and vaccine coverage, it can be useful in most parts of the world.

By highlighting the impact of mask use and vaccination on infection risk during high case count periods, the paper informs policy decisions on COVID-19 case thresholds for introducing mask mandates and other interventions.

Journal reference:
Susha Cheriyedath

Written by

Susha Cheriyedath

Susha is a scientific communication professional holding a Master's degree in Biochemistry, with expertise in Microbiology, Physiology, Biotechnology, and Nutrition. After a two-year tenure as a lecturer from 2000 to 2002, where she mentored undergraduates studying Biochemistry, she transitioned into editorial roles within scientific publishing. She has accumulated nearly two decades of experience in medical communication, assuming diverse roles in research, writing, editing, and editorial management.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cheriyedath, Susha. (2023, August 16). CovARC: a streamlined, scalable and accurate COVID-19 risk calculation system. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20230816/CovARC-a-streamlined-scalable-and-accurate-COVID-19-risk-calculation-system.aspx.

  • MLA

    Cheriyedath, Susha. "CovARC: a streamlined, scalable and accurate COVID-19 risk calculation system". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20230816/CovARC-a-streamlined-scalable-and-accurate-COVID-19-risk-calculation-system.aspx>.

  • Chicago

    Cheriyedath, Susha. "CovARC: a streamlined, scalable and accurate COVID-19 risk calculation system". News-Medical. https://www.news-medical.net/news/20230816/CovARC-a-streamlined-scalable-and-accurate-COVID-19-risk-calculation-system.aspx. (accessed November 21, 2024).

  • Harvard

    Cheriyedath, Susha. 2023. CovARC: a streamlined, scalable and accurate COVID-19 risk calculation system. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20230816/CovARC-a-streamlined-scalable-and-accurate-COVID-19-risk-calculation-system.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Limited impact of prenatal COVID-19 exposure on child neurodevelopmental outcomes